T-cell Acute Lymphoblastic Leukemia
Also known as: Acute T Cell Lymphoblastic Leukemia / T-Lymphocytic Leukemia, Acute / T-Cell Acute Lymphocytic Leukemia / Adult Acute Lymphocytic Leukemia T-Cell / T-Acute Lymphoblastic Leukemia / Leukemia, Lymphocytic, Acute, T-Cell / Leukemia, Lymphoblastic, Acute, T Cell / T Cell Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute, T-cell / T-cell Lymphoblastic Leukemia / Acute T-cell Lymphoblastic Leukemia / T-cell acute lymphoblastic leukemia (T-ALL) / Acute T-cell lymphoblastic leukaemia / Acute T-lymphoblastic Leukemia / Acute T Lymphoblastic Leukemia (T-ALL) / T-All / Precursor T-Cell Lymphoblastic Leukemia / Lymphoblastic Leukemia, Acute T-cell / T Acute Lymphoblastic Leukemia / Acute T-Lymphocytic Leukemia / T-cell Adult Acute Lymphoblastic Leukemia (ALL) / T-cell Adult Acute Lymphoblastic Leukemia / Adult T Acute Lymphoblastic Leukemia / T-lymphoblastic leukemia (disorder) / T-cell lymphoblastic leukemia acute / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / T-lymphoblastic leukemia (morphologic abnormality) / T-cell type acute leukemia / T-cell type acute leukaemia / T-cell lymphoblastic leukaemia acute
Drug | Drug Name | Drug Description |
---|---|---|
DB01280 | Nelarabine | A purine nucleoside analog and antineoplastic agent used for the treatment of with acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments. |